Genelancet Biosciences Inc.
Doylestown, PA
- UEI
- DN5PLRA5PM23
- CAGE
- 8Q692
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- Other NAICS codes in SAM.gov
- SAM.gov registration date
- Physical address
- 3805 Old Easton Rd, Doylestown, PA 18902, USA
- Website
- genelancetbio.com
- Employees
- 1-10
- Estimated annual revenue
- $0-$1M
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Biotechnology
- SIC code
- 28 Chemical & Allied Products
- Profiles
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Grant awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| Development of star editors (crispr-CAS9/lgrna-ssdna) for the cure of chronic hepatitis b | National Institute of Allergy and Infectious Diseases (NIH) | $600,000 |
Grant subawards
| Prime recipient | Prime award | Amount | Awarded |
|---|---|---|---|
| Baruch S. Blumberg Institute | R21AI179930 | $189,875 |
SBA capabilities narrative
GeneLancet provides high-quality single-molecule guide RNAs (lgRNA), crRNA, tracrRNA and their conjugates for CRISPR/Cas applications in the formats of either single tubes or plates.
Quick answers
Is Genelancet Biosciences Inc. registered in SAM.gov?
Yes. Genelancet Biosciences Inc.'s SAM.gov registration is active through March 11, 2027.
What is Genelancet Biosciences Inc.'s most recent federal award?
Genelancet Biosciences Inc.'s most recent federal grant award is Development of star editors (crispr-CAS9/lgrna-ssdna) for the cure of chronic hepatitis b (R43AI164976), from National Institute of Allergy and Infectious Diseases (NIH), on August 9, 2022.
On GovTribe
See Genelancet Biosciences Inc.'s full federal record
- Federal grant awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors